Related Experiment Video
Updated: Feb 24, 2026

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
Nitazoxanide Analogs Require Nitroreduction for Antimicrobial Activity in Mycobacterium smegmatis
Maria V Buchieri1, Mena Cimino1, Sonia Rebollo-Ramirez2
1Unité de Génétique Mycobactérienne, Institut Pasteur , 25 Rue du Docteur Roux, 75724 Paris Cedex 15, France.
Mycobacterium smegmatis naturally resists a novel nitazoxanide analog due to nitroreductase NfnB. Overexpressing this enzyme increases sensitivity, revealing a key drug metabolism pathway for developing new mycobacterial treatments.
Area of Science:
- Microbiology
- Drug Discovery
- Biochemistry
Background:
- Mycobacteria exhibit natural resistance to antimicrobial compounds.
- High-throughput screening (HTS) is crucial for identifying novel drug candidates.
- Understanding resistance mechanisms is key to developing effective treatments.
Purpose of the Study:
- To investigate natural resistance mechanisms in mycobacteria against novel compounds.
- To identify the specific gene and protein responsible for resistance to a nitazoxanide analog.
- To elucidate the metabolic pathway required for the compound's antibacterial activity.
Main Methods:
- Whole-cell-based high-throughput screening (HTS) using Mycobacterium aurum.
- Resistance mechanism analysis in Mycobacterium smegmatis against compound 3 (a nitazoxanide analog).
- Gene knockout and overexpression studies focusing on the nfnB gene encoding nitroreductase NfnB.
Main Results:
- Identification of 3-bromo-N-(5-nitrothiazol-2-yl)-4-propoxybenzamide as a compound with activity against mycobacteria.
- Repression of the nfnB gene confers natural resistance in M. smegmatis.
- Overexpression of nfnB leads to increased sensitivity to the compound, indicating NfnB's role in metabolism.
- The compound requires metabolism into a hydroxylamine intermediate for antibacterial action.
Conclusions:
- Nitroreductase NfnB plays a critical role in the natural resistance of M. smegmatis to a nitazoxanide analog.
- Metabolism of nitro compounds by mycobacterial nitroreductases is species-specific.
- Nitro drugs show potential as antibacterials across various bacterial species, pending understanding of their metabolic activation.
Related Concept Videos
Phase I Reactions: Reductive Reactions
Preparation of Amines: Reduction of Oximes and Nitro Compounds
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Gene Regulation in Microbial Communities: Quorum Sensing
Diazonium Group Substitution: –OH and –H

